Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2023


Werte in diesem Artikel
Aktien

0.72 EUR -0.01 EUR -0.96 %


Strasbourg, January 4, 2024 – 05:45 pm CET

Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of December 31, 2023, the following resources were managed through the liquidity account:

Werbung

  • 303,861 shares
  • € 125,121.00

In the second half of 2023, a total of:

Purchases 157,564 shares€ 249,580651 market transactions
Sales133,103 shares€ 219,772613 market transactions

It is recalled that when the liquidity program was initially established in 2016, the following resources were made available:

Cash balance of the liquidity contract: € 500,000.00

At the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:

Werbung

  • 164,183 shares
  • € 246,158.00

Contacts

Transgene:

Arnaud DUBARRY
CFO
+33 (0)3 88 27 91 00
investorrelations@transgene.fr
 

Attachment


Werbung

Transgene Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Transgene nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"

Keine Analysen gefunden.